Aralez Pharmaceuticals Inc. et al v. Teva Pharmaceuticals USA, Inc. et al
| Aralez Pharmaceuticals Inc., Aralez Pharmaceuticals Trading DAC, Aralez Pharmaceuticals US Inc. and Pozen Inc. |
| Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. |
| 2:2017cv00071 |
| January 23, 2017 |
| US District Court for the Eastern District of Texas |
| Marshall Office |
| Anderson |
| Rodney Gilstrap |
| Roy S. Payne |
| Patent |
| 35 U.S.C. ยง 271 |
| None |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
68
ORDER ADOPTING REPORT AND RECOMMENDATION for 64 Report and Recommendation, Teva's 67 Objections OVERRULED; 38 Motion to Dismiss filed by Teva Pharmaceuticals USA, Inc. DENIED. Signed by Judge Rodney Gilstrap on 8/10/2017. (slo, )
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Texas Eastern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
